New Key Statistics Module, Z-Score and F-Score
OTCPK:BVAXF Key Ratios
Market Cap $ M | 11.53 |
Enterprise Value $ M | 12.36 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -0.03 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -2.98 |
EV-to-EBITDA | -2.98 |
PEG | -- |
Shares Outstanding M | 246.93 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 0.14 |
Current Ratio | 0.14 |
ROA % (ttm) | -354.80 |
ROE % (ttm) | -- |
ROIC % (ttm) | -646.69 |
Dividend Yield % | -- |
Altman Z-Score | -- |
BVAXF Number of Guru Trades
BVAXF Volume of Guru Trades
Gurus Latest Trades with OTCPK:BVAXF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:BVAXF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
BioVaxys Technology Corp Insider Transactions
No Available Data
News about OTCPK:BVAXF
Total 0- 1